Cooke W J, Cooke L
Drug Metab Dispos. 1977 Jul-Aug;5(4):368-76.
Biliary excretion, plasma decay, and tissue distribution of 125I after a single intravenous dose (13 mumol/kg) of 125I-Iopanoate and 125I-iopanoate glucuronide were compared in control and phenobarbital-pretreated rats under either anesthesia. In control animals the plasma decay of iopanoate glucuronide following iopanoate glucuronide administration was significantly greater than that after iopanoate administration. Biliary clearance following iopanoate glucuronide was approximately 20 times greater than that after iopanoate; within 60 min, 82% of the dose of iopanoate glucuronide, compared to 23% of the dose of iopanoate, was recovered in bile. Phenobarbital pretreatment significantly increased the biliary excretion following iopanoate administration but had no effect on that following iopanoate glucuronide. The urinary excretion after both agents was less than 3% of the administered dose within the 60-min experimental period. The data suggest that intracellular metabolism and/or binding may account for the marked difference in the biliary excretion of iopanoate glucuronide following iopanoate as compared to that after administration of iopanoate glucuronide.
在麻醉状态下,对对照组和苯巴比妥预处理的大鼠,比较单次静脉注射剂量(13 μmol/kg)的125I-碘番酸和125I-碘番酸葡糖醛酸苷后的胆汁排泄、血浆衰减及组织分布。在对照动物中,给予碘番酸葡糖醛酸苷后其血浆衰减显著大于给予碘番酸后的血浆衰减。碘番酸葡糖醛酸苷后的胆汁清除率约为碘番酸后的20倍;在60分钟内,胆汁中回收的碘番酸葡糖醛酸苷剂量的82%,而碘番酸剂量仅为23%。苯巴比妥预处理显著增加了碘番酸给药后的胆汁排泄,但对碘番酸葡糖醛酸苷给药后的胆汁排泄无影响。在60分钟的实验期内,两种药物后的尿排泄均小于给药剂量的3%。数据表明,细胞内代谢和/或结合可能是碘番酸葡糖醛酸苷与碘番酸给药后胆汁排泄存在显著差异的原因。